Motley Fool Wealth Management LLC Cuts Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Key Points

• Motley Fool Wealth Management LLC sold 11,262 shares of HealthEquity, lowering its holdings by 8.2%, with a total ownership of approximately 0.15% of the company valued at $11.1 million.
• HealthEquity received upgrades from several analysts, with price targets increased to as high as $125.00, reflecting a consensus rating of "Buy" among analysts.
• Insider transactions revealed significant sales by executives, with a total of 291,744 shares sold in the last quarter, valued at over $32 million.

Motley Fool Wealth Management LLC lessened its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 8.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 125,467 shares of the company's stock after selling 11,262 shares during the quarter. Motley Fool Wealth Management LLC owned approximately 0.15% of HealthEquity worth $11,088,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in HQY. Transce3nd LLC bought a new position in HealthEquity during the 4th quarter worth approximately $29,000. Versant Capital Management Inc bought a new position in HealthEquity during the 1st quarter worth approximately $28,000. Larson Financial Group LLC raised its holdings in HealthEquity by 1,366.0% during the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares during the last quarter. Whipplewood Advisors LLC raised its holdings in HealthEquity by 5,060.0% during the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after purchasing an additional 759 shares during the last quarter. Finally, UMB Bank n.a. raised its holdings in HealthEquity by 104.8% during the 1st quarter. UMB Bank n.a. now owns 848 shares of the company's stock worth $75,000 after purchasing an additional 434 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

HealthEquity Stock Down 2.1%

NASDAQ HQY traded down $1.84 during mid-day trading on Thursday, hitting $87.43. The company's stock had a trading volume of 1,066,898 shares, compared to its average volume of 1,013,921. The company's 50 day simple moving average is $99.36 and its 200 day simple moving average is $97.59. HealthEquity, Inc. has a twelve month low of $71.33 and a twelve month high of $116.65. The company has a current ratio of 4.06, a quick ratio of 4.06 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $7.56 billion, a price-to-earnings ratio of 63.82, a PEG ratio of 1.44 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The business had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. During the same quarter last year, the firm posted $0.80 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have issued reports on HQY. Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. JMP Securities raised their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Raymond James Financial restated a "strong-buy" rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Barrington Research raised their price objective on shares of HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a research report on Thursday, June 5th. Finally, Bank of America lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $118.55.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. The trade was a 3.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jon Kessler sold 97,767 shares of HealthEquity stock in a transaction on Friday, June 6th. The stock was sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the transaction, the director directly owned 75,000 shares in the company, valued at $8,403,750. This represents a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.